Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2021.03.02.433594

MEG Oscillatory and Aperiodic neural dynamics contribute to different cognitive aspects of short-term memory decline through the lifespan

Thuwal, K.·Banerjee, A.·Roy, D.
View original source ↗Export metadata ↓

Abstract

Neural communication or signal transmission in the brain propagates via distinct oscillatory frequency bands. With aging, the communication mediated by these frequency bands is hindered by noise, which arises from the increased stochastic variability in the baseline neural spiking. This increase in noise measured as 1/f power-law scaling reflects the global background noise and is often linked to impaired cognition in different tasks. In this study, we quantified the 1/f slope and intercept of MEG brain signal as a putative marker of neural noise and examined its effect on cognitive and metacognitive measures. We hypothesize that as neural communication becomes noisier with age, it impacts global information processing, whereas specific periodic features mediate local aspects of cognition. Using recently proposed parametric Fooof model, we first characterised the normative pattern of periodic and aperiodic features (temporal dynamics) across the lifespan, modelled via spectral peaks (Central frequency, power, bandwidth) and 1/f noise activity (slope and intercept) respectively. Secondly, how this Resting-State (RS) baseline shift in temporal dynamics of the signal is associated with various aspects of visual short-term memory (VSTM). Our results suggest that age-associated global change in noisy baseline affects global information processing and crucially impacts the oscillatory features, which relates to more local processing and selective behavioural measures in the VSTM task. Moreover, we suggest that the task-related differences observed across age groups are due to the baseline shift of periodic and aperiodic features. Significant statementAging is accompanied by the decline in cognitive functions and age itself is a major risk factor for Alzheimers Disease and other neurological conditions. Our study provides MEG 1/f aperiodic and periodic markers across the healthy adult lifespan and shows that different frequency bands and their spectral features mediate age-related changes across different brain regions, in multiple cognitive and metacognitive domains, which not only provides us with a better understanding of the aging process but would also help in better prevention of cognitive impairments. A clear characterization of the association between baseline MEG temporal dynamics, healthy aging and cognition, is established in this study.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Thuwal, K., Banerjee, A., Roy, D.. 2021-03-02. MEG Oscillatory and Aperiodic neural dynamics contribute to different cognitive aspects of short-term memory decline through the lifespan. https://doi.org/10.1101/2021.03.02.433594

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗